Clinical trials sponsored by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase breakdown

Conditions studied

Recruiting trials led by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

• HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
  NCT06709885 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
  NCT06848465 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma
  NCT07468630 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
  NCT06633133 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Daping Hospital and the Research Institute of Surgery of the Third Military Medical University recruiting for?

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.